Submitted by shiva on
Top Industry News
- EMA Encourages Companies to Submit Type I Variations for 2018 by End of November 2018
- HPRA- Guide to Labels and Leaflets of Human Medicines
- SFDA- Integration Guide for Drug Track & Trace System
- FDA- M9 Biopharmaceutics Classification System-Based Biowaivers
- Australian Regulatory Guidelines for Medical Devices (ARGMD)
- Health Canada- Consultation on Proposed Revisions to the Guidance Document: Management of Drug Submissions
- HPRA- Guide to Traditional Herbal Medicinal Products Registration Scheme
- EMA- Quick Interactive Guide to EudraVigilance (EV) Registration Process
- FDA Finalizes Testicular Toxicity Guidance
- TGA- Provisional Registration Extension and Transition to Full Registration
- FDA- Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs